Detalles de la búsqueda
1.
Evaluation of oral tenofovir disoproxil fumarate and topical tenofovir GS-7340 to protect infant macaques against repeated oral challenges with virulent simian immunodeficiency virus.
J Acquir Immune Defic Syndr
; 43(1): 6-14, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16810108
2.
Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV.
J Acquir Immune Defic Syndr
; 38(2): 124-34, 2005 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15671796
3.
Topical administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against multiple oral exposures of low doses of simian immunodeficiency virus.
J Infect Dis
; 186(10): 1508-13, 2002 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12404171
4.
CD8+-cell-mediated suppression of virulent simian immunodeficiency virus during tenofovir treatment.
J Virol
; 78(10): 5324-37, 2004 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15113912
5.
The clinical benefits of tenofovir for simian immunodeficiency virus-infected macaques are larger than predicted by its effects on standard viral and immunologic parameters.
J Acquir Immune Defic Syndr
; 36(4): 900-14, 2004 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15220696
Resultados
1 -
5
de 5
1
Próxima >
>>